hajiahmadi, nazila, Mojtahedzade, Faezeh, Yari, Atefeh, Tat, Mahdi, Soleimanjahi, Hoorieh, amel jamehdar, saeed, Jafari, Mitra, Asli, Samira, Dorostkar, Roohollah, Nazemipour, Maryam, Mansournia, Mohammad Ali, Bamdad, Taravate (2022). Association of Anti-N and -S Seroprevalence in Asymptom atic, Mildly Symptomatic, and Symptomatic SARS-COV-2 Natural Infection. , 8(4), 357-364. doi: 10.52547/iem.8.4.357
nazila hajiahmadi; Faezeh Mojtahedzade; Atefeh Yari; Mahdi Tat; Hoorieh Soleimanjahi; saeed amel jamehdar; Mitra Jafari; Samira Asli; Roohollah Dorostkar; Maryam Nazemipour; Mohammad Ali Mansournia; Taravate Bamdad. "Association of Anti-N and -S Seroprevalence in Asymptom atic, Mildly Symptomatic, and Symptomatic SARS-COV-2 Natural Infection". , 8, 4, 2022, 357-364. doi: 10.52547/iem.8.4.357
hajiahmadi, nazila, Mojtahedzade, Faezeh, Yari, Atefeh, Tat, Mahdi, Soleimanjahi, Hoorieh, amel jamehdar, saeed, Jafari, Mitra, Asli, Samira, Dorostkar, Roohollah, Nazemipour, Maryam, Mansournia, Mohammad Ali, Bamdad, Taravate (2022). 'Association of Anti-N and -S Seroprevalence in Asymptom atic, Mildly Symptomatic, and Symptomatic SARS-COV-2 Natural Infection', , 8(4), pp. 357-364. doi: 10.52547/iem.8.4.357
hajiahmadi, nazila, Mojtahedzade, Faezeh, Yari, Atefeh, Tat, Mahdi, Soleimanjahi, Hoorieh, amel jamehdar, saeed, Jafari, Mitra, Asli, Samira, Dorostkar, Roohollah, Nazemipour, Maryam, Mansournia, Mohammad Ali, Bamdad, Taravate Association of Anti-N and -S Seroprevalence in Asymptom atic, Mildly Symptomatic, and Symptomatic SARS-COV-2 Natural Infection. , 2022; 8(4): 357-364. doi: 10.52547/iem.8.4.357

Association of Anti-N and -S Seroprevalence in Asymptom atic, Mildly Symptomatic, and Symptomatic SARS-COV-2 Natural Infection

Infection Epidemiology and Microbiology
Article 8, Volume 8, Issue 4, 2022, Pages 357-364    PDF (453.36 K)
Document Type: Original Research
DOI: 10.52547/iem.8.4.357
Authors
nazila hajiahmadi1; Faezeh Mojtahedzade1; Atefeh Yari1; Mahdi Tat2; Hoorieh Soleimanjahi1; saeed amel jamehdar3; Mitra Jafari1; Samira Asli4; Roohollah Dorostkar5; Maryam Nazemipour6; Mohammad Ali Mansournia* 7; Taravate Bamdad1
1Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran
2Department of Virology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, IranApplied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
3Antimicrobial resistance research center, Mashhad University of Medical Sciences, Mashhad, Iran. Clinical Research Development center, Akbar hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
4Clinical Research Development center, Akbar hospital, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
5Applied Virology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
6Osteoporosis Research Center, Endocrinology and Metabolism Clinical Science Institute, Tehran University of Medical sciences, Tehran, Iran.
7Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran.
Abstract
Backgrounds: SARS-COV-2 infection is not always correlated with protection. Antibody seroprevalence in unvaccinated individuals, which is usually measured by N-specific antibodies, is not necessarily correlated with protection, while antibodies against S protein show a better correlation with protection due to its neutralizing epitopes. In this study, we tried to improve our conception of the hidden perspective of SARS-COV-2 in epidemiological reports and investigate anti-S antibody prevalence among anti-N antibody-positive asymptomatic and mildly symptomatic patients.

Materials & Methods: Blood samples were collected from asymptomatic or mildly symptomatic volunteer participants and symptomatic hospitalized patients with negative PCR results from May 30 to June 17, 2020. Detection of SARS-COV-2 antibodies was done using an ELISA kit targeting N or S protein.

Findings: Totally, 716 samples from volunteer participants and 81 samples from symptomatic hospitalized patients with negative PCR results were evaluated. The test performance-adjusted seroprevalence (95% CI) of SARS-COV-2 antibody was 17.3% (8.8-25.8%) for anti-N IgG in volunteers and 25.5% (12.8-39.7%) for anti-N and anti-S IgM in hospitalized patients. Among anti-N IgG positive infected individuals, 49.2% (21.4 and 78.8%) were anti-S antibody positive.

Conclusion: The results showed that SARS-COV-2 infection sometimes occurs in individuals without symptoms or with mild symptoms, but in more than half of them, the produced antibody is not protective. The findings of hospitalized patients showed that the combination of IgM assay with real-time PCR improved the disease diagnosis by more than 25% in cases with negative molecular test results.
Keywords
Antibody; Covid-19; Epidemiology; SARS-CoV-2; Seroprevalence
References
Statistics
Article View: 124
PDF Download: 79
Statistics
Number of Journals45
Number of Issues2,174
Number of Articles24,684
Article View25,078,720
PDF Download17,777,879